Clinical Trial Market Research Reports & Industry Analysis

The global AI in biotechnology market is projected to reach USD 22,716.5 million by 2035 from USD 4,156.9 million in 2025, at a high CAGR of 18.5% during the forecast period. The market is progressing steadily, driven by the growing adoption of AI for predictive analytics in drug safety and efficacy ...

Key Highlights The argininosuccinic aciduria market is anticipated to sustain a steady Compound Annual Growth Rate (CAGR) during the forecast period (2025–2034). This growth in market revenue is primarily propelled by advancements in diagnostic techniques, heightened awareness of the condition, and ...

Key Highlights Although considered rare, the true prevalence of EDS is anticipated to be higher than currently appreciated, primarily due to a lack of awareness among the healthcare community. Hypermobile Ehlers-Danlos Syndrome (hEDS) is the most common subtype of EDS, accounting for approximately 9 ...

Key Highlights Alkaptonuria or ""black urine disease,"" is a rare genetic disorder now manageable with Food and Drug administration (FDA)-approved HARLIKU (nitisinone), which, alongside dietary restrictions of tyrosine and phenylalanine, helps reduce toxic HGA buildup and slow disease progression. A ...

Key Highlights With declining rates of head and neck cancers related to alcohol and tobacco, HPV has become the principal etiologic factor in OPSCC, redefining prognostic outlooks and informing the development of tailored therapeutic approaches. Patients with HPV-positive oropharyngeal tumors exhibi ...

The global locally advanced pancreatic cancer market size reached US$ 1.31 billion in 2024 and is expected to reach US$ 2.38 billion by 2033, growing at a CAGR of 7.0% during the forecast period 2025-2033. Locally advanced pancreatic cancer refers to a stage of pancreatic cancer where the tumor is c ...

Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2025 provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report pro ...

Report Scope The report examines trends in the global market for AI in clinical trials. It segments the global market by component, phase, deployment mode, therapeutic area and end user. It also provides insights into key emerging trends and potential growth drivers. Components consist of software a ...

Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2025 provides an overview of Dry (Atrophic) Macular Degeneration Clinical trials scenario. This report provides ...

Lupus Nephritis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Lupus Nephritis - Global Clinical Trials Review, 2025 provides an overview of Lupus Nephritis Clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephr ...

IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “IgA Nephropathy (Berger's Disease) - Global Clinical Trials Review, 2025 provides an overview of IgA Nephropathy (Berger's Disease) Clinical trials scenario. This report provides top ...

China's Evolution in Global Drug Development and Clinical Trials Summary In 2015, China’s state council launched ‘Opinions on Deepening the Reform of the Review and Approval Processes to Encourage Innovation of Drugs and Medical Devices,’ which was the catalyst of change to implement several regulat ...

The Clinical Trial Supply and Logistics Market for Pharma 2025-203 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies ...

Global e-Clinical Trial Technologies Market to Reach US$31.1 Billion by 2030 The global market for e-Clinical Trial Technologies estimated at US$14.8 Billion in the year 2024, is expected to reach US$31.1 Billion by 2030, growing at a CAGR of 13.1% over the analysis period 2024-2030. Clinical Trial ...

Global Artificial Intelligence in Clinical Trials Market to Reach US$3.5 Billion by 2030 The global market for Artificial Intelligence in Clinical Trials estimated at US$1.6 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 202 ...

Global Electronic Data Capture Market to Reach US$2.7 Billion by 2030 The global market for Electronic Data Capture estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 13.6% over the analysis period 2024-2030. Services Component, one of the ...

Global Healthcare Contract Research Organization (CRO) Market to Reach US$83.6 Billion by 2030 The global market for Healthcare Contract Research Organization (CRO) estimated at US$61.1 Billion in the year 2024, is expected to reach US$83.6 Billion by 2030, growing at a CAGR of 5.4% over the analysi ...

Global Regulatory Affairs Outsourcing Market to Reach US$9.2 Billion by 2030 The global market for Regulatory Affairs Outsourcing estimated at US$5.6 Billion in the year 2024, is expected to reach US$9.2 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Regulatory Submis ...

Global eClinical Solutions Market to Reach US$22.7 Billion by 2030 The global market for eClinical Solutions estimated at US$11.4 Billion in the year 2024, is expected to reach US$22.7 Billion by 2030, growing at a CAGR of 12.2% over the analysis period 2024-2030. Web-Hosted (on-demand) Delivery, on ...

Global Veterinary Clinical Trials Market to Reach US$7.6 Billion by 2030 The global market for Veterinary Clinical Trials estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.6 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Companion Animal, one of ...

Global Alzheimer’s Disease Drugs Market to Reach US$12.3 Billion by 2030 The global market for Alzheimer’s Disease Drugs estimated at US$8.9 Billion in the year 2024, is expected to reach US$12.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Donepezil, one of the seg ...

Global Artificial Intelligence-based Clinical Trial Solutions for Patient Matching Market to Reach US$2.4 Billion by 2030 The global market for Artificial Intelligence-based Clinical Trial Solutions for Patient Matching estimated at US$641.6 Million in the year 2024, is expected to reach US$2.4 Bill ...

Global Ophthalmic Clinical Trials Market to Reach US$2.7 Billion by 2030 The global market for Ophthalmic Clinical Trials estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 6.3% over the analysis period 2024-2030. Drugs, one of the segment ...

Global Clinical Trial Management Systems (CTMS) Market to Reach US$4.5 Billion by 2030 The global market for Clinical Trial Management Systems (CTMS) estimated at US$2.0 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 14.6% over the analysis period 2024-20 ...

Global Clinical Trial Imaging Market to Reach US$1.4 Billion by 2030 The global market for Clinical Trial Imaging estimated at US$1.0 Billion in the year 2024, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Project & Data Management Service ...